These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 26444056)
1. Cardioprotection and arrhythmias, Part I. Baczkó I; Jost N; Varró A Can J Physiol Pharmacol; 2015 Jul; 93(7):v. PubMed ID: 26444056 [No Abstract] [Full Text] [Related]
2. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. Bian JS; Yong QC; Pan TT; Feng ZN; Ali MY; Zhou S; Moore PK J Pharmacol Exp Ther; 2006 Feb; 316(2):670-8. PubMed ID: 16204473 [TBL] [Abstract][Full Text] [Related]
3. Role of endogenous oxytocin in cardiac ischemic preconditioning. Alizadeh AM; Faghihi M; Sadeghipour HR; Mohammadghasemi F; Khori V Regul Pept; 2011 Feb; 167(1):86-90. PubMed ID: 21130120 [TBL] [Abstract][Full Text] [Related]
4. Is oxytocin a therapeutic factor for ischemic heart disease? Alizadeh AM; Mirzabeglo P Peptides; 2013 Jul; 45():66-72. PubMed ID: 23659864 [TBL] [Abstract][Full Text] [Related]
5. Activation of cardiac M3 muscarinic acetylcholine receptors has cardioprotective effects against ischaemia-induced arrhythmias. Wang S; Han HM; Jiang YN; Wang C; Song HX; Pan ZY; Fan K; Du J; Fan YH; Du ZM; Liu Y Clin Exp Pharmacol Physiol; 2012 Apr; 39(4):343-9. PubMed ID: 22224440 [TBL] [Abstract][Full Text] [Related]
6. Cardioprotection and arrhythmias, Part 2. Baczkó I; Jost N; Varró A Can J Physiol Pharmacol; 2015 Sep; 93(9):v. PubMed ID: 26444207 [No Abstract] [Full Text] [Related]
7. Gap junctions in preconditioning against arrhythmias. Lascano EC; Negroni JA Cardiovasc Res; 2007 Jun; 74(3):341-2. PubMed ID: 17459356 [No Abstract] [Full Text] [Related]
9. Clinical translation of cardioprotective strategies : report and recommendations of the Hatter Institute 5th International Workshop on Cardioprotection. Hausenloy DJ; Yellon DM Basic Res Cardiol; 2008 Sep; 103(5):493-500. PubMed ID: 18600363 [No Abstract] [Full Text] [Related]
11. Cardioprotection by volatile anesthetics: established scientific principle or lingering clinical uncertainty? Pagel PS J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):589-93. PubMed ID: 19789055 [No Abstract] [Full Text] [Related]
12. Preconditioning with Porphyromonas gingivalis lipopolysaccharide may confer cardioprotection and improve recovery of the electrically induced intracellular calcium transient during ischemia and reperfusion. Fan MH; Wong KL; Wu S; Leung WK; Yam WC; Wong TM J Periodontal Res; 2010 Feb; 45(1):100-8. PubMed ID: 19602110 [TBL] [Abstract][Full Text] [Related]
13. Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs. Papp JG; Pollesello P; Varró AF; Végh AS J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):129-35. PubMed ID: 16891290 [TBL] [Abstract][Full Text] [Related]
14. Cardiomyopathy. Purcell JA; Holder CK Am J Nurs; 1989 Jan; 89(1):57-74B. PubMed ID: 2642662 [No Abstract] [Full Text] [Related]
15. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart. Hajrasouliha AR; Tavakoli S; Ghasemi M; Jabehdar-Maralani P; Sadeghipour H; Ebrahimi F; Dehpour AR Eur J Pharmacol; 2008 Jan; 579(1-3):246-52. PubMed ID: 17950273 [TBL] [Abstract][Full Text] [Related]